Micro-x Ltd. · ASX:MX1
Micro-x — HealthInvest, Sydney 2026
12 slides from Micro-x's conference presentation, Jun 3, 2026
Slide 1: Reimagining Medical Imaging Through Portable CT
For personal use only REIMAGINING MEDICAL IMAGING THROUGH PORTABLE CT HealthIn ve st, Sydney 3 June 2026 Kingsley Hall C h i e f E x e c u t iv e O f f i c e r Micro-X HealthInvest – 3 June 2026 I 1
Slide 2: Important Notice
IMPORTANT NOTICE S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the For personal use only Company’s assets and liabilities, financial positi
Slide 3: Creating Revolutionary X-ray Imaging to Better Lives
For personal use only CREATING REVOLUTIONARY X-RAY IMAGING TO BETTER LIVES Curious I Collaborative I Determine d Micro-X HealthInvest – 3 June 2026 I 3
Slide 4: Next-Generation CT Imaging Platform
NEXT-GENERATION CT IMAGING PLATFORM Technology enables entirely new medical CT imaging use cases Proprietary Nano Electronic X-ray (NEX) platform For personal use only → A true structural technology advancement reducing size, weight and complexity → Cold cathode carbon nanotube X-ray a technology le
Slide 5: Why Portable CT Matters
WHY PORTABLE CT MATTERS Size, weight and cost of conventional CT limits progress in global healthcare priorities CT is a clinically accepted diagnostic tool for top global diseases For personal use only → Ischaemic heart disease- #1 cause of death → Stroke – #2 cause of death 30/60/90 National Strok
Slide 6: Solving the CT Technology Moat
SOLVING THE CT TECHNOLOGY MOAT Proprietary and customisable technology enables use across multiple applications For personal use only NEX TUBES HIGH VOLTAGE GENERATOR MULTI-TUBE SWITCHING ARRAY RECONSTRUCTION SOFTWARE Cold cathode using proprietary carbon nanotube emitter CT architecture combines mu
Slide 7: Rover – Proven Technology
ROVER – PROVEN TECHNOLOGY Delivering on securing larger contracts and direct sales focus Lighter, faster, reliable mobile X-ray For personal use only → Full medical performance in a mobile system → 40% lower mAs1 Approvals Large tender opportunities and GPOs FDA → $3.3M order for Malaysian Ministry
Slide 8: Head CT – A New Imaging Category
HEAD CT – A NEW IMAGING CATEGORY Hospital and ambulance trials ahead of FY2027 regulatory applications Taking diagnosis to the patient to save precious time For personal use only → ~70kg and able to fit in a standard road or air ambulance → Designed to inform pre-hospital clinical diagnosis of type
Slide 9: Full Body CT – Designing Prototype
FULL BODY CT – DESIGNING PROTOTYPE Bringing full diagnostic CT scanning to the patient For personal use only Up to $25M development funding contract with US Govt biomedical research agency ARPA-H → Initial funding of $12.5M for first 2 years - up to $25M for a total of 5 years → Contract to design a
Slide 10: Corporate & Financials
CORPORATE Institutional/ Strategic 40.0% & FINANCIALS Retail and HNW 57.5% For personal use only Board & Management 2.5% FINANCIALS & SHAREHOLDERS SHARE CAPITAL (29 May 2026) $22.2m Contracted Payments FY26 onwards Cash $3.5m (31 March 2026) Share price $0.043 per share $13.1m (FY2025) Shares on iss
Slide 11: Wrap Up
WRAP UP NEX Technology platform to scale For personal use only 1 Proprietary CT imaging platform 2 Positioned at the intersection of CT and decentralised healthcare 3 Multiple ways to win through funded developments 4 Near term clinical and commercial catalysts 5 NEX Technology enables portable CT M
Slide 12: For personal use only
For personal use only For more information visit: www.micro-x.com Micro-X Limited Investor Enquiries Kingsley Hall, Chief Executive Officer Peter Dickman Rebecca Puddy, Head of Corporate Chief Financial Officer Communications Tel: +61 8 7099 3966 Tel: +61 8 7099 3966 Email: pdickman@micro-x.com Emai